Chelsea Clinton joins Nurx to boost telemedicine for birth control

Nurx—a San Francisco-based telemedicine firm that provides birth-control services—announced Chelsea Clinton will join its board of directors. The startup, launched in 2014, recently raised $36 million in Series B funding in hopes of developing a comprehensive reproductive health platform.

Nurx, currently available in 17 states, allows individuals with a smartphone to consult medical professionals and receive prescriptions for birth control and HIV-prevention medication. Users can also receive referrals for other services.

“With efforts you see around the country to further restrict reproductive health access, we need to set the bar high to connect people with information and birth control access,” Clinton said. “We want to see as much innovation both in for-profit and not-for-profit models for sustained access, and this is a moment where we are more likely to see that in a private company.”

With the recent influx of funding, Nurx executives hope to hire more nurses and further develop its network of medical professionals.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.